Glial cell isolation. Forebrains were dissected from postnatal day 3-5 wild-type mice and were manually dissociated into ~0.5 mm 2 pieces in a total of 2 ml of HBSS. A total of 500 l of 2.5% trypsin were added and dissociated tissue was incubated at 37°C for 20 min. Solution was mixed every 5 min. Using a pipette, the remaining tissue was further dissociated and passed through a 70 M nylon mesh filter (BD Biosciences) into DMEM with 10% Fetal Bovine Serum and L-glutamine. Glia cells were passaged three times before culturing with human neuronal cells. These procedures were approved by the Rutgers University Institutional Animal Care and Use Committee (#I11-073-10).
Electrophysiology.
The pipette solution for current-clamp experiments consisted of (in mM): 123 K-gluconate, 10 KCl, 1 MgCl 2 , 10 HEPES, 1 EGTA, 0.1 CaCl 2 , 1 K 2 ATP, 0.2 Na 4 GTP and 4 glucose. The pH of the solution was adjusted to 7.2 with KOH. A membrane potential of −65 to −70 mV was maintained during current-clamp recordings, and currents were injected into the cell in a step-wise manner to stimulate action potentials. For whole-cell voltage-dependent current recordings, the same internal solution as described above was used. For evaluation of synaptic function, the internal solution consisted of (in mM): 135 CsCl, 10 HEPES, 1 EGTA, 4 Mg-ATP, 0.4 Na 4 GTP, and 10 QX-314, pH 7.4. The bath solution consisted of (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 HEPES, and glucose, pH 7.4. Stimulus artifacts in the recording, when stimuli were provided during evoked synaptic responses, were removed in the graphical representation of the data.
Antibodies. The following primary antibodies were used: Mouse anti-TH (Millipore, 1:1000), Mouse antiVglut1 (Synaptic Systems, 1:500), mouse anti-TuJ1 (Covance, 1:1000), rabbit anti-Synapsin (Abcam, 1:500), mouse anti-MAP2 (Millipore, 1:500), rabbit anti-DAT (Millipore, 1:250). After additional PBS washes, cells were incubated with fluorescently labeled secondary antibodies from Molecular probes (Alexa 488, Alexa 594, or Alexa 647) used at 1:500 dilution.
Supplemental Table 1 . Subjects used in this study. All SNP genotypes were confirmed by PCR in iPSC DNA. Gender  Status  rs880395  rs16969968  rs1799971  rs8192475  rs12914008  rs56218866   Group   70  Male  Affected  GG  AA  AA  GG  GG  TT  N398  67  Female  Affected  GG  AA  AA  GG  GG  TT  N398  31  Female  Affected  GG  AA  AA  GG  GG  TT  N398  37  Female  Control  GG  GG  AA  GG  GG  TT  D398  73  Female  Control  GG  GG  AA  GG  GG  TT  D398  41  Male  Control  GG  GG  AA  GG  GG  TT  D398   Supplemental Table 2 . PluriTest algorithm values. As comparison, H1 hESC sample is used as a control for pluripotency and crude cryopreserved lymphocytes (CPL) as well as enriched CD4 + T-cells serve as controls for differentiated cells. Samples from iPSC cell line 03, not used in this study, are included to match the source CPL and T-cell samples. Two different passages of line 70 and one from 41 are included to demonstrate pluripotency of iPSC lines used in this study. According to Müller et al. (2012) , pluripotency can be identified with the pluripotency score greater than 20 and a novelty score less than 1.67. All iPSC pass these thresholds. TiPSC: T-cell-derived iPSC. 
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